Zhengye Biotechnology Revenue Falls 18.3%, Net Loss Narrows 13.3%
For the six months ended June 30, 2026, revenue fell 18.3% to RMB50.9 million and gross profit declined to RMB16.7 million. Net loss narrowed 13.3% to RMB22.2 million versus the same period last year.
For the six months ended June 30, 2026, revenue fell 18.3% to RMB50.9M and gross profit declined to RMB16.7M. Net loss narrowed 13.3% to RMB22.2M; comparisons are with the same period last year.Material DetailsContext by AI AnalystThis is a mid-cycle operating update: revenue and gross profit decli…